Mr. Richard David Kuo has served NonExecutive Independent Director of Probiotec Ltd since July 28, 2006. He holds MAICD. He holds Commerce and Law degrees with post graduate qualifications in applied finance and investment. Brings with him 26 years experience in law, investment banking and corporate strategy. Currently manages Pier Capital, a privately owned investment banking firm which provides corporate advice to a broad range of corporations and has experience in mergers and acquisitions, capital markets and strategic planning. He is NonExecutive Director of Glenorchy Art and Sculpture Park Limited.
Director Since 2006
The company has return on total asset (ROA) of (0.05) % which means that it has lost $0.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (0.79) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 27.07 M in total debt with debt to equity ratio (D/E) of 0.43 which is about average as compared to similar companies. Probiotec Limited has Current Ratio of 0.66 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Entity SummaryProbiotec Limited engages in the development, manufacture, and sale of pharmaceuticals, foods, and nutraceutical solutions in Australia and internationally. Probiotec Limited [PBP] is traded on Australian Securities Exchange in Australia. It is located in Laverton North, VIC and employs 18 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| PBP Australian
Benchmark S&P 500
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
Probiotec Limited has less than 48.99 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Probiotec price boundaries
Promote Probiotec and Richard Kuo